Mitsubishi UFJ Trust & Banking’s Tarsus Pharmaceuticals TARS Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$253K	Buy	+4,018	New	+$257K	﹤0.01%	1272

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's TARS Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 4,018 shares worth $253K. The stake represents ﹤0.01% of the portfolio and ranks #1272 among its holdings.

87 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 4,018 shares of Tarsus Pharmaceuticals worth $253K as of Q2 2026.
Tarsus Pharmaceuticals was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Tarsus Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1272 holding.
87 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.